Clinical trial
The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions…
NCT00002404 · Glaxo Wellcome, Industry · Completed
Key facts
| NCT number | NCT00002404 |
|---|---|
| Title | The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected Patients |
| Official title | The Effect of Treatment With Valacyclovir 500 mg BID on the Detection of HIV From Genital HSV Lesions in HIV-Infected Patients: A Double-Blind Crossover Study |
| Lead sponsor | Glaxo Wellcome, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Herpes Simplex, HIV Infections |
| Intervention type | Drug |
| Interventions | Valacyclovir hydrochloride |
| Enrollment | 30 |
| First posted | Aug 31, 2001 |
| Last update posted | Jan 29, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: